| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |